Synaptic targeting by A beta oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease.
about
Amyloid-β oligomers induce synaptic damage via Tau-dependent microtubule severing by TTLL6 and spastinNeuroprotective Mechanisms Mediated by CDK5 InhibitionBrain interstitial oligomeric amyloid β increases with age and is resistant to clearance from brain in a mouse model of Alzheimer's disease.Interrogating global gene expression in rat neuronal cultures using SAGE.Differential effects of amyloid-β peptide aggregation status on in vivo retinal neurotoxicityLinking type 2 diabetes and Alzheimer's disease.The intersection of amyloid beta and tau at synapses in Alzheimer's diseaseModulation of amyloid-β aggregation by histidine-coordinating Cobalt(III) Schiff base complexes.ERP abnormalities elicited by word repetition in fragile X-associated tremor/ataxia syndrome (FXTAS) and amnestic MCI.Functional alterations in memory networks in early Alzheimer's disease.Impaired regulation of synaptic actin cytoskeleton in Alzheimer's disease.Aβ oligomers-induced toxicity is attenuated in cells cultured with NbActiv4™ mediumAmyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigreesCSF levels of oligomeric alpha-synuclein and beta-amyloid as biomarkers for neurodegenerative disease.Neuronal amyloid-β accumulation within cholinergic basal forebrain in ageing and Alzheimer's disease.Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.Computational modeling of the relationship between amyloid and disease.Parishin C's prevention of Aβ 1-42-induced inhibition of long-term potentiation is related to NMDA receptorsMolecular mechanisms of the conjugated alpha,beta-unsaturated carbonyl derivatives: relevance to neurotoxicity and neurodegenerative diseases.Advances on the understanding of the origins of synaptic pathology in AD.Glial and endothelial blood-retinal barrier responses to amyloid-beta in the neural retina of the ratAbnormal P600 word repetition effect in elderly persons with preclinical Alzheimer's disease.Amyloid oligomers: dynamics and toxicity in the cytosol and nucleus.Current Update on Synopsis of miRNA Dysregulation in Neurological Disorders.Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of ageCan size alone explain some of the differences in toxicity between beta-amyloid oligomers and fibrils?Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers.Cholinergic Surveillance over Hippocampal RNA Metabolism and Alzheimer's-Like Pathology.The microtubule-associated protein 1A (MAP1A) is an early molecular target of soluble Aβ-peptide.Synaptic dysfunction in Alzheimer's disease: the effects of amyloid beta on synaptic vesicle dynamics as a novel target for therapeutic intervention.
P2860
Q24337233-E048AD09-E726-4759-8EEA-226228BDD2D0Q28082792-112490BE-AC69-473D-A58B-C46287823590Q33289360-BF17E42B-0840-40B4-B4C6-874DACD06C68Q33315212-DD78AA16-022C-443E-BE06-0E9218227B92Q33702093-093CCAF5-B6BE-4BD6-8151-A02AE0EE8116Q33859703-6790BAEF-0503-4598-803A-CC003DEA9303Q34054680-E5BB6267-7EB3-4075-8B2D-85C5ACED10AEQ34199803-5AB06140-6383-485A-B474-3E3410F854D1Q34324687-58465AD0-2061-4090-AEFD-B9AD6E7B6DBBQ34565270-B45852B9-1F9B-4A4F-9EC2-7FC7C27B5247Q35027999-500A7D90-0928-4F89-9B0E-64B4154BCC37Q35327150-6B4871C0-88CF-45ED-9FDD-C28626526333Q35694218-AF23CB13-F77B-4F8B-8F5A-6362CDB75072Q35906655-A72859F2-4BBA-4822-82F2-BD117DFF18AFQ35974488-3CDCFA38-6D63-4985-8C06-FD388A72E367Q36538283-4D3B811B-5134-4A10-8A8E-482EAB2D74C7Q36677013-82673E02-47E7-459C-B358-080F5CFC7748Q36870599-44323075-668B-42FC-BE5F-FC98B6F41F2CQ37033629-1929DE2F-EDB9-4C4B-8B09-48FB351AD337Q37108156-79C8A617-C2E0-4CEC-92DB-9EE9208B447DQ37236088-12A362B0-6C62-4091-A127-3EB36BFFB376Q37344434-0C04347C-75B9-4E9A-A81B-E957D35CA135Q37690821-55BB1615-1F26-4F5B-96B7-A962ED041581Q38365159-DD4B65CB-FFF2-4C13-91BD-976BB1087B63Q38793564-8FAA51CC-7B11-4137-B18D-7FFD8ABFA123Q42093156-C964F20E-E787-4004-967E-03EB5FE263A8Q43509033-F3151E0D-F526-4258-86AB-F4A899370101Q48671012-A0DEB77D-BAA6-4F6C-B4F9-492201A537AFQ48709443-A5BE3724-C320-499E-91B7-F47C60847140Q53513746-62C5C9C8-0776-499D-9BEE-18B12FEB2E11
P2860
Synaptic targeting by A beta oligomers (ADDLS) as a basis for memory loss in early Alzheimer's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Synaptic targeting by A beta o ...... in early Alzheimer's disease.
@en
Synaptic targeting by A beta oligomers
@nl
type
label
Synaptic targeting by A beta o ...... in early Alzheimer's disease.
@en
Synaptic targeting by A beta oligomers
@nl
prefLabel
Synaptic targeting by A beta o ...... in early Alzheimer's disease.
@en
Synaptic targeting by A beta oligomers
@nl
P1476
Synaptic targeting by A beta o ...... in early Alzheimer's disease.
@en
P2093
William L Klein
P356
10.1016/J.JALZ.2005.11.003
P577
2006-01-01T00:00:00Z